Drug Type asPNA |
Synonyms |
Target |
Mechanism MYC inhibitors(Myc proto-oncogene protein inhibitors), Genetic transcription inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
C-Myc positive Solid Tumors | Preclinical | IT | 20 Nov 2023 |